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The risk factors for sudden infant death syndrome (SIDS) parallel those associated with sus-
ceptibility to or severity of infectious diseases.There is no evidence that a single infectious
agent is associated with SIDS; the common thread appears to be induction of inflammatory
responses to infections. In this review, interactions between genetic and environmental
risk factors for SIDS are assessed in relation to the hypothesis that many infant deaths
result from dysregulation of inflammatory responses to “minor” infections. Risk factors
are assessed in relation to three important stages of infection: (1) bacterial colonization (fre-
quency or density); (2) induction of temperature-dependent toxins; (3) induction or control
of inflammatory responses. In this article, we review the interactions among risk factors for
SIDS for their effects on induction or control of inflammatory responses. The risk factors
studied are genetic factors (sex, cytokine gene polymorphisms among ethnic groups at
high or low risk of SIDS); developmental stage (changes in cortisol and testosterone levels
associated with 2- to 4-month age range); environmental factors (virus infection, exposure
to cigarette smoke).These interactions help to explain differences in the incidences of SIDS
observed between ethnic groups prior to public health campaigns to reduce these infant
deaths.
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INTRODUCTION
Sudden infant death syndrome (SIDS) is still the major cause of
death between 1 month to 1 year of age among infants in indus-
trialized countries. SIDS is a diagnosis of exclusion. The original
definition was “. . . the sudden death of any infant or young child,
which is unexpected by history, and in which a thorough post
mortem examination fails to demonstrate an adequate cause of
death” (1).The definition was revised in 1989 to “the sudden death
of an infant under one year of age, which remains unexplained
after a thorough case investigation, including performance of a
complete autopsy, examination of the death scene, and review of
the clinical history” (2) Comparison of epidemiological data from
different countries found that infants of some ethnic groups had
an increased risk of SIDS (Table 1).
The pathogenesis of SIDS has been examined by many disci-
plines. These have made significant contributions to the study of
infant deaths and put forward hypotheses; however, many cannot
explain the risk factors or the positive effects of the public health
campaigns to reduce the risk (10). The idea that inflammation
might be involved in these infant deaths is not new. In an arti-
cle published in 1956, 126 non-traumatic sudden (“unexplained”)
infant deaths were investigated; 106 (84%) revealed microscopic
inflammatory changes in 1 or more sites of the respiratory tract,
and there was histologic evidence of inflammatory disease in
other organs in many cases (11). Table 2 summarizes some of
the evidence for inflammatory responses in sudden infant deaths.
RISK FACTORS FOR SIDS AND SUSCEPTIBILITY TO
INFECTION
Epidemiological studies found significant associations between
SIDS and a variety of genetic, developmental, and environmen-
tal factors (Table 3). When these factors are compared with those
associated with increased susceptibility to bacterial infections,
there are remarkable parallels. Each of these factors can affect
one or more of the important stages in susceptibility to or sever-
ity of infections: frequency or density of bacterial colonization
of mucosal surfaces; induction of temperature-dependent toxins;
induction or control of inflammatory responses to infection. Each
of these is described in detail below.
Infectious agents or their products have been identified during
autopsies of SIDS infants and more recently in sudden unex-
pected death of infancy (SUDI), which is defined as the sudden
and unexpected death of an infant under 1 year of age; SUDI
includes explained deaths and those that, after investigation of the
death scene and meticulous post-mortem examination, remain
unexplained (42). For many years, microbiological findings were
dismissed as contamination, overgrowth, or normal flora. More
recent studies have questioned these assertions and have provided
evidence to support the likelihood that post-mortem bacteriology
is a true reflection of infection in these infant deaths (42–44). The
common bacterial toxin hypothesis (45–47) considered a number
of the risk factors in a mathematical model. It has been supported
by identification of potentially toxigenic bacteria or their toxins in
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Table 1 | Variation in the incidence of SIDS among ethnic groups
within countries before the “reduce the risks” campaigns.
Country Ethnic group SIDS/1,000 live births Reference
Australia Aboriginal 6.1 (3)
Non-aboriginal 1.7
United Kingdom European 1.7 (4)
Bangladeshi 0.3
United States Total population 2 (5–7)
Oriental 0.3
African-American 5.0
Native-American 5.9
Alaskan-Natives 6.3
New Zealand Maori 7.4 (8, 9)
Non-Maori 3.6
Table 2 | Inflammatory or immune responses identified in SIDS infants.
Organ system Response Reference
Respiratory
tract
Peribronchial inflammatory infiltrates (12, 13)
Increase in IgM producing cells in
trachea
(14)
Mast cell degranulation (15) (Walls,
this issue)
Digestive
tract
Increased IgA producing cells in
duodenum
(14)
Increased salivary IgA (16)
Nervous
system
Interferon alpha in neurons of the
medulla of the brain
(17)
Increased levels of IL-6 in spinal fluid (18)
Lymphocyte infiltration (19)
Blood Decreased IgG response to bacterial
toxins
(20, 21)
Increased IgM response to core
endotoxin
(21)
Increased levels of mast cell tryptase (15)
Increased levels of mannose binding
lectin
(22)
Cross-linked fibrin degradation
products
(23)
SIDS and sudden unexpected deaths in infancy (SUDI) (Table 4).
Many of the bacterial toxins or components of the bacteria impli-
cated can act as super antigens, eliciting powerful cytokine storm
responses such as those seen in toxic shock syndrome or bacterial
sepsis.
The infection hypothesis does not fit Koch’s postulates. That
is, there is no single organism implicated and there is no widely
accepted animal model that reflects the genetic, developmental,
and environmental risk factors identified in epidemiological stud-
ies (see Blood-Siegfried, this issue). In addition, a variety of viruses
have been identified in SIDS infants (67–69). Sterile site infections
have been identified in SUDI, and a variety of toxigenic bacteria
Table 3 | Risk factors for SIDS that parallel risk factors for
susceptibility of infants to infection.
Risks Reference
Genetic
Ethnicity (3–7, 9, 24)
Male gender (25–27)
Developmental
Night time deaths (28, 29)
Peak age range 2–4 months (25)
Environmental
Prone sleeping (25, 30)
Cigarette smoke exposure (25, 28)
Overheating (31)
Mild respiratory infections (25, 31, 32)
Lack of breast feeding (33)
Poor socio-economic conditions (25, 34)
No or late immunization (35, 36)
Air pollution (37)
Used cot mattress (38, 39)
Day care (40)
Older siblings (41)
Table 4 |Toxigenic bacteria and their toxins implicated in sudden
death in infancy.
Toxin Reference
Staphylococcus aureus Enterotoxins, TSSTa (48–50)
Bordetella pertussis Pertussis toxin, endotoxina (51–53)
Haemophilus influenzae Endotoxina (54)
Clostridium perfringens Enterotoxin Aa (55, 56)
Clostridium botulinum Botulism toxin (57–59)
Streptococcus pyogenes Pyrogenic toxins A and Ba (54)
Escherichia coli Enterotoxins, verotoxins (60–63)
Curlina (64)
Helicobacter pylori Endotoxin, vacuolatinga toxin,
urease
(65)
Pneumocystis ? (66)
aSuperantigenic activity.
?, toxin/antigen unknown.
or their toxins have been reported in these infant deaths (Table 4).
Our hypothesis is that there is not a particular organism or toxin,
the factor in these deaths is the dysregulation of the inflamma-
tory responses elicited by what appear to be mild or asymptomatic
infections.
The objective of this review was to assess how the risk factors
identified in epidemiological studies of SIDS affect susceptibil-
ity to infection and/or alter inflammatory responses to infections.
It addresses the interactions between these identified risk factors
and the three key stages of infection: (1) increased frequency or
density of bacterial colonization; (2) induction of temperature-
dependent toxins; (3) induction or control of inflammatory
responses (Table 5).
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Table 5 | How do risk factors for SIDS affect susceptibility to infection.
Effects on frequency or density of colonization by bacteria by
Developmental stage/expression of receptors
Prone position
Virus infection
Cigarette smoke
Day care
Older siblings
Effects on temperature-dependent bacterial toxin production by
Overheating
Prone position
Virus infection
Effects on induction or control of inflammatory responses by
Cigarette smoke
Virus infection
Sex
Genetic background
Developmental stage (low maternal antibodies, cortisol levels,
testosterone surge)
BACTERIAL COLONIZATION
Factors affecting colonization have been elucidated in previous
studies. Virus infections, which often precede SIDS or SUDI, can
enhance bacterial binding through induction of host receptors for
bacteria or induction of new receptors (70, 71). The prone posi-
tion can lead to pooling of respiratory secretions and increased
numbers and varieties of bacteria, particularly in the presence of
virus infection (72). Active smoking can predispose individuals to
virus infections, and smokers are colonized more heavily and more
frequently with potential pathogens (73). In addition to enhancing
susceptibility to virus infections, material in cigarette smoke can
passively coat epithelial cells and enhance “stickiness” for poten-
tial pathogens (74). Exposure of infants to new infectious agents
can be enhanced by day care with other children or older siblings
attending nursery or school outside the home environment.
TEMPERATURE-DEPENDENT TOXINS
The pyrogenic toxins of Staphylococcus aureus have been identi-
fied in over half of SIDS infants from five different countries (50).
S. aureus is the most common isolate from the nasopharynx of
healthy infants, and 64% of these have the capacity to produce
these toxins (75). The toxins are induced only between 37 and
40°C, and the temperature of the nasopharynx is usually below
this range (76). In the prone position, the temperature in the
nasopharynx of children is increased and 15% had temperatures
≥37°C. While the toxigenic organisms are present in most infants,
induction of the toxin is likely to be dependent on risk factors such
as overheating, prone position, or virus infection with associated
blocked nasal passages that result in reduced cooling effects of the
passage of air.
INFLAMMATION AND SIDS
The common thread in these deaths is not a single organism or
toxin; it is dysregulation of the innate inflammatory responses
in the non-immune infant or young child who encounters a
new potential pathogen. There is recent evidence that a balanced
inflammatory response during infancy is important for survival.
In a study of low birth weight infants, cytokine responses were
assessed in vitro by stimulation of whole blood cultures with
lipopolysaccharide (LPS), phytohemagglutinin (PHA), or puri-
fied protein derivative (PPD). Infants whose cytokine responses to
LPS or PHA were very low or very high were at increased risk of
death assessed by survival of the cohort tested. The interpretation
of these findings was that a balanced response to new pathogens
was more likely to result in survival (77). A variety of bacteria
implicated in SIDS/SUDI possess structural antigens or exotoxins
that can act as superantigens (e.g., LPS) that can activate large
populations of inflammatory cells (Table 3).
Inflammation can be assessed from clinical evidence, histolog-
ical findings, or molecular markers. Clinical evidence of inflam-
mation has been identified in some of these infant deaths. Infants
were very hot when found and remained hot for several hours
after death (78). Histological signs of inflammation are consid-
ered the gold standard by the clinical pathologist and some of
these are summarized in Table 2. It has been suggested that mol-
ecular markers of inflammation need to be measured; however,
these are relatively expensive and are not usually included in stan-
dard autopsy protocols. To date, there have been few studies of
inflammatory markers in sudden deaths (18, 79, 80). Because
these components are not regularly examined during autopsy, co-
operation with a research group with an interest in inflammation
would help to obtain evidence for these markers.
INFLAMMATION IN RELATION TO PROPOSED MECHANISMS
OF DEATH IN SIDS
Cytokines produced in the inflammatory responses to infectious
agents could have an impact on most of the mechanisms of death
proposed: anaphylaxis; poor arousal; hypoxia and apnea; shock;
cardiac arrythmias; hyperthermia; hypoglycemia (81). Anaphy-
laxis was the first mechanism proposed in an animal model in
which guinea pigs were sensitized to cow’s milk (82, 83). Studies
of SIDS infants have not found evidence to support the hypothesis
that IgE-mediated anaphylaxis is involved in these infant deaths.
There is evidence, however, for degranulation of mast cells in
some infants (15) (Walls, this issue). In addition, in an in vitro
study of first degree relatives of SIDS infants or infants who had
suffered an acute life threatening episode (ALTE), there was evi-
dence of increased mast cell hyper-releasability and degranulation
(84). This could be mediated by some of the pyrogenic staphy-
lococcal toxins through non-antibody activation of mast cells.
The toxins, which are super antigens, can bind directly to the
Vβ antigens on mast cells and trigger degranulation indepen-
dent of antibody and complement. A mild virus infection might
enhance colonization by S. aureus and increased temperature of
the oropharynx due to blocked nasal passages. This could result
in temperatures that are permissive for induction of the staphy-
lococcal toxins. Increased production of interferon-γ (IFN-γ)
and/or other mediators could enhance expression of Vβ anti-
gens which are receptors for the toxins. Cross-linking of the Vβ
antigens by the toxins could lead to non-IgE-mediated degranu-
lation of mast cells (Figure 1). Evidence of mast cell tryptase and
other products of mast cells have been published (15) (Walls, this
volume).
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1.  Mild virus infection                          a) enhanced staphylococcal colonisation
b) Increased nasopharyngeal temperature due to 
blocked nose (permissive temperature for 
induction of staphylococcal toxins)
c) induction of IFN-γ
2   IFN-γ a) enhancement of MHC receptors on mast cells
3.  Staphylococcal toxins bind MHC class II antigens on mast cells and trigger release of 
contents
Toxin heparin
TNF-α
tryptase
degranulation
FIGURE 1 | Proposed scheme for interactions between virus infections and pyrogenic staphylococcal toxins in non-antibody-mediated induction of
mast cell degranulation (see text).
IN VITRO STUDIES OF INFLAMMATION IN HUMAN
MATERIAL
The inflammatory responses can be affected by genetic, devel-
opmental, and environmental factors. In vitro studies need to
consider these potential confounding factors. Taking blood from
young infants is not practical for most studies, so cell lines or adult
leukocytes have been used to assess the effects of risk factors for
SIDS on inflammation. In addition to controlling for confounding
factors, it is important to use biologically relevant concentrations
of substances to be assessed in the model system (85).
While bacteria and their toxins have been implicated in SIDS,
there is epidemiological and experimental evidence for virus infec-
tions acting as a cofactor. Many parents reported their child had
a mild cold or sniffle prior to death. The presence of a risk factor
such as prone sleeping, head covered, or parental smoking com-
bined with infection was associated with a greater risk of SIDS
than the individual risk factor alone (32).
In animal models, the lethal doses of both staphylococcal exo-
toxins (86) and endotoxin (87–89) were significantly reduced if the
animals had mild/asymptomatic virus infection. Virus infections
induce IFN-γ, which can significantly enhance production of pro-
inflammatory cytokines (Moscovis et al., this volume). IL-6 has
been identified in the CSF of SIDS infants (18). We demonstrated
a dose-dependent enhancement by IFN-γ of IL-6 elicited by LPS
in a human cell line and human peripheral blood monocytic cells
(PBMC) (85). In addition, in a model system, IFN-γ has been
demonstrated to reduce significantly the anti-inflammatory IL-
10 responses elicited from human PBMC exposed to endotoxin
(Moscovis et al., this volume).
In contrast, components of cigarette smoke, such as nicotine
(or its liver metabolite cotinine), can suppress endotoxin-induced
IFN-γ, IL-1β, TNF-α, and IL-8. There are, however, limitations in
using single purified reagents for in vitro studies as the responses
elicited might not reflect accurately the complex interactions
that occur in vivo. Nicotine is only one of approximately 4,000
chemicals in cigarette smoke. A water soluble cigarette smoke
extract (CSE) enhanced IL-8 responses but reduced other pro-
inflammatory cytokines (85). In vitro studies found cells from
smokers produced significantly lower anti-inflammatory IL-10
responses than cells of non-smokers (90). This could impair the
ability to control pro-inflammatory responses to infection.
DEVELOPMENTAL STAGE AND SIDS
The mathematical model used for the common bacterial toxin
hypothesis predicted the 2- to 4-month age range as that dur-
ing which the peak of SIDS occurred. This prediction fits the
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epidemiological data. There are a number of factors that could
contribute to susceptibility to infection during his period: (1) loss
of maternal antibody; (2) development of circadian rhythms and
the associated changes in night time cortisol; (3) the testosterone
surge in males between 1 and 5 months.
ANTIBODY LEVELS AND THE EFFECTS OF IMMUNIZATION
An important factor is the loss of maternal antibodies, which make
the infants more reliant on their innate inflammatory responses
to cope with new infections. This can include exposure to new
infections brought home by older siblings or attendance at day
care, both of which have been identified as risk factors for SIDS
in epidemiological studies. Immunization has been demonstrated
to be a protective factor in relation to SIDS (35). Most infants
start their immunizations during the period of peak vulnerability,
but they will not be fully immunized to common childhood ill-
nesses implicated in some epidemiological studies (e.g., whooping
cough) by 4 months of age. The protective effect of immunization
was noted in early studies (35), and a shift in the age range of SIDS
in infants in both Scotland and England was observed following
changes in the immunization of infants in UK. That is, immuniza-
tion began at 2 months instead of 3 months (91). It has also been
demonstrated that some cross protection against staphylococcal
exotoxins was elicited in animals by tetanus toxoid (91).
DEVELOPMENT OF CIRCADIAN RHYTHM AND HORMONAL CHANGES
During the first months of life, significant physiological changes
occur which could affect control of the inflammatory responses.
Circadian rhythm develops between 4 and 16 weeks in Caucasian
infants in Britain, but this does not occur until 12–20 weeks in
Asian infants (92). The switch to circadian rhythm is measured by
the night time drop in core body temperature. This physiological
switch is accompanied by a dramatic drop in night time, but not
daytime, cortisol levels (Figure 2).
The levels of night time cortisol after the switch were not capa-
ble of reducing pro-inflammatory responses in a model system
examining inflammatory responses of peripheral blood mono-
cytes to staphylococcal toxins (93). Daytime levels and night time
FIGURE 2 | Day time and night time cortisol levels of infants in relation
to development of circadian rhythm and potential for control of
inflammatory responses to infection [adapted from Ref. (92)].
levels prior to the switch were able to reduce these responses. If
these in vitro studies reflect the activity of cortisol in vivo in the
infant, this 2- to 4-month period could be a window of vulnera-
bility to new infections, particularly at night. The circadian switch
occurs later among Asian infants (12–20 weeks), which allows time
for natural exposure to infection or immunization to boost spe-
cific immunity. Prior to the public health campaigns to reduce the
risks of SIDS, there was a lower incidence of SIDS among Asian
infants in UK compared with infants of European origin (4).
THE EFFECT OF TESTOSTERONE
The male excess in SIDS noted in epidemiological studies and
assessed in mathematical models (26) might reflect hormonal
changes that occur during the period in which SIDS is most preva-
lent. There is a rise in testosterone production associated with
the period during which SIDS is most prevalent. Between 1 and
5 months, testosterone levels range from 0.03 to 6.14 nMol L−1
for males and 0.03 to 0.17 nMol L−1 for females. In males, these
levels decrease to 0.07–0.24 at 6–11 months (94). In a previ-
ous study (95), the ranges of testosterone in the adult females
(<0.4–3.1 nMol L−1) tested were within the range for males in
the 1- to 5-month age range (94). In the model system exam-
ined, there was a positive correlation between testosterone levels
and pro-inflammatory responses to LPS when the cells were pre-
treated with IFN-γ or IFN-γ and CSE. No correlations were
observed for the higher levels (6.3–21 nMol L−1) found in adult
males (95).
These findings indicate that in addition to low levels of night
time cortisol present in infants over the age range of greatest
risk of SIDS (93), dysregulation of the inflammatory responses
to apparently “mild” infections might be amplified by the increase
in testosterone in male infants at this time. As this does not occur
in female infants, this could be an additional factor contributing
to the higher proportion of males among SIDS infants. In vitro
studies using the PBMC model might provide additional insights
into the interactions between cortisol and testosterone levels noted
in infants during this critical age range.
INTERACTIONS WITH GENETIC FACTORS
Among the ethnic groups at increased risk of SIDS (e.g., indige-
nous populations in Australia and North America and Black Amer-
icans), there is a higher proportion of genotypes associated with
strong pro-inflammatory responses (96–98). While these dispari-
ties have been ascribed primarily to socio-economic disadvantage,
there is emerging evidence that genetic background and inter-
actions between environmental factors such as cigarette smoke
might contribute to susceptibility and severity of infections (85,
90). Of particular importance is the effect of cigarette smoke on
the genotype of IL-10 (G-1082A) associated with lower levels of
the anti-inflammatory response. The AA genotype is predominant
among the groups at higher risk of SIDS, and in our in vitro stud-
ies, cells from smokers with this genotype had the lowest responses
(90). Among the ethnic groups at increased risk of SIDS, there
is also a higher incidence of maternal smoking. South Asians
have genetic profiles similar to those for the higher risk groups;
however, smoking is much less prevalent among south Asian
women in UK.
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Our experimental studies indicate that higher IFN-γ responses
might elicit higher pro-inflammatory responses to bacterial tox-
ins (Moscovis et al., this volume). Indigenous Australians tested
had the highest proportion of individuals with the TT genotype
of IFNG T+ 874A (96), which is associated with high IFN-γ
responses observed in vitro (99).
CONCLUSION
There is a wealth of knowledge about the risk factors for sudden
death in infancy; it is important, however, to attempt to explain
how these risk factors could result in death. There is a growing
body of evidence that infection and inflammatory responses might
trigger the events leading to sudden death in infancy. A recent
review on infectious causes of SIDS concluded no specific organ-
ism was involved in SIDS (100). The evidence of Anderson et al.
(77) indicates that a balanced inflammatory response is impor-
tant for dealing with new infections. Our hypothesis is that the
common thread in these deaths is dysregulation of the inflam-
matory responses to apparently mild infections. The risk factors
identified in epidemiological studies can have significant effects
on inflammatory responses that could affect the different physio-
logical mechanisms proposed to explain these infant deaths (81).
Many of the genetic, developmental, and environmental factors
identified could affect this balance resulting in enhanced pro-
inflammatory cytokine levels, which can affect glucose levels, heart
rate, apnea, arousal, anaphylaxis, and shock. The components of
the inflammatory responses involved might differ in individual
children; however, it is the dysregulation of the responses that lead
to the death of the child. We need to investigate further the inter-
actions between genetic, developmental, and environmental risk
factors on inflammatory responses to attempt to identify infants
at increased risk and to attempt to introduce measures to prevent
induction of these lethal responses.
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